Home
Login
Register
Live
Users
Tag cloud
Published News
Upcoming News
Submit a new story
World Pharma News Home
»
Product
»
GlaxoSmithKline responds to FDA on Cervarix® and plans to submit final study data for approval
->
Get all Published News delivered to your inbox!
(a free service delivered by FeedBurner)
1
Vote
GlaxoSmithKline responds to FDA on Cervarix® and plans to submit final study data for approval
Posted by
worldpharmanews
102 days ago
(
http://www.worldpharmanews.com
)
View profile
Category
:
Product
|
Tags
:
glaxosmithkline
cervarix
GlaxoSmithKline provided the following update regarding its application to the U.S. Food and Drug Administration (FDA) for approval of Cervarix®, its vaccine to prevent cervical cancer.
Discuss
Add this link to...
Bury
Add to:
|
Bookmarks
Comments
Who Voted
Related Links
Comments
Log in to comment
or register
here
.
Who voted for this story
worldpharmanews
Related Links
GSK's continued commitment to fighting HIV/AIDS results in approval of new formulations
GlaxoSmithKline and OncoMed Pharmaceuticals form strategic alliance
GlaxoSmithKline buoyed by Buffett stake - Times Online
EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline
New price reductions for GSK antiretrovirals in the world's poorest countries
alliConnect - GlaxoSmithKline's official product blog
Update on GSK's malaria treatments: Dacart and Lapdap
FDA grants Priority Review For Promacta/Revolade (Eltrombopag)
Pharmalot » Glaxo Escapes Prosecution Over Paxil In UK
GSK statement on MHRA investigation
What is World Pharma News?
World Pharma News .net is the first worldwide Web 2.0 pharmaceutical news service developed on the top of the World Pharma News .com Project.
Login
|
Register
Top Today
1
EMEA half-year report for 2008...
Published News
1
EMEA half-year report for 2008...
1
Genzyme Recognized by Scientis...
3
Drug Injury Watch: Congress Wi...
1
New Media Offers Cost-Efficien...
1
Medicines regulators on both s...
Categories
Blogs
Clinical Trials
Conferences & Events
Corporate
Financial
Product
Publications
Research & Development
Top Tags
bayer
drug-injury
drug-safety
fda
glaxosmithkline
novartis
pfizer
pharma
pharmalot
vytorin
read more
Comments